Lipocine Inc.
- Industry Drug Manufacturers - Specialty & Generic
- Sector Healthcare
- Market Cap
- Earnings
About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
LPCN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Lipocine GAAP EPS of -$0.13 in-line, revenue of $0.5M misses by $0.91M
- Lipocine GAAP EPS of -$0.03 in-line
- Lipocine announces plans to focus on treating CNS disorders, shares rise ~5%
- Lipocine GAAP EPS of -$0.04 in-line, revenue of $0.5M beats by $0.24M
- Lipocine stock rises premarket after being granted two U.S. patents
- Lipocine GAAP EPS of -$0.04 misses by $0.02
- Antares wins full FDA approval for testosterone replacement therapy
- Lipocine GAAP EPS of -$0.01, revenue of $16.1M
- Lipocine announces FDA accepted the marketing application for Tlando
- Catalyst watch for next week: Earnings blitz headlined by Apple, Microsoft, Boeing and Tesla
- Dosing underway in Lipocine's mid-stage LPCN 1148 study for liver cirrhosis
- Lipocine EPS beats by $0.01
- Lipocine shares jump 9% after FDA Fast Track status for LPCN 1144 NASH treatment
- Lipocine shares rise after TLANDO licensing agreement with Antares Pharma
- FDA affirms class 1 NDA resubmission for Lipocine's Tlando
- Lipocine discloses mid-stage data for NASH candidate
- Lipocine EPS misses by $0.03
- Lipocine enters settlement and license agreement with Clarus Therapeutics
- Cantor initiates Lipocine with an overweight rating, sees 121% upside
- Lipocine soars 9% on FDA greenlight for Phase 2 LPCN 1154 study in postpartum depression
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| November 10, 2021 | -0.03 / -0.0425 | 54.99K / - |
Beat! |
| August 10, 2021 | - / -0.05 | - / - | |
| May 10, 2021 | - / -0.07 | - / - | |
| March 11, 2021 | -0.18 / -0.0633 | - / - | |
| November 10, 2020 | -0.07 / -0.06 | - / - | |
| August 6, 2020 | -0.13 / -0.07 | - / - | |
| May 7, 2020 | -0.14 / -0.08 | - / - | |
| March 13, 2020 | -0.1 / -0.1 | - / 146K | |
| November 12, 2019 | -0.12 / -0.21 | 164.99K / 36.33K |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9 | 1.5000 | 1.4500 |
1.5500
|
1.4200
|
1.14M | 6.38% | ||||
| Mar 8 | 1.4100 | 1.5300 |
1.5499
|
1.3300
|
1.80M | -6.62% | ||||
| Mar 7 | 1.5100 | 1.4800 |
1.6000
|
1.4520
|
1.38M | 0.67% | ||||
| Mar 4 | 1.5000 | 1.4000 |
1.5000
|
1.4000
|
1.38M | 6.38% | ||||
| Mar 3 | 1.4100 | 1.3100 |
1.4200
|
1.2900
|
1.31M | 8.46% | ||||
| Mar 2 | 1.3000 | 1.2700 |
1.3100
|
1.2200
|
548.04K | 2.36% | ||||
| Mar 1 | 1.2700 | 1.2200 |
1.2800
|
1.2200
|
538.28K | 3.25% | ||||
| Feb 28 | 1.2300 | 1.2300 |
1.2600
|
1.2000
|
253.00K | 0.82% | ||||
| Feb 25 | 1.2200 | 1.2000 |
1.2400
|
1.1700
|
301.53K | 3.39% | ||||
| Feb 24 | 1.1800 | 1.1220 |
1.2000
|
1.0700
|
649.77K | 0.85% | ||||
| Feb 23 | 1.1700 | 1.1700 |
1.2300
|
1.1700
|
655.48K | 0% | ||||
| Feb 22 | 1.1700 | 1.2346 |
1.2346
|
1.1500
|
603.27K | -6.4% | ||||
| Feb 18 | 1.2500 | 1.2300 |
1.3000
|
1.2001
|
772.04K | 2.46% | ||||
| Feb 17 | 1.2200 | 1.2640 |
1.2700
|
1.2012
|
617.31K | -1.61% | ||||
| Feb 16 | 1.2400 | 1.1600 |
1.2500
|
1.1300
|
612.35K | 6.90% | ||||
| Feb 15 | 1.1600 | 1.1100 |
1.1800
|
1.1067
|
339.91K | 5.45% | ||||
| Feb 14 | 1.1000 | 1.0600 |
1.1100
|
1.0514
|
239.58K | 2.80% | ||||
| Feb 11 | 1.0700 | 1.0900 |
1.1000
|
1.0500
|
171.73K | -2.73% | ||||
| Feb 10 | 1.1000 | 1.0300 |
1.1500
|
1.0300
|
377.71K | 3.29% | ||||